All News

Lower patient caps shift costs to community pharmacies, fueling pharmacy benefit manager fees, mail-order growth, and pharmacy deserts.

Pharmacists can review medications that delay wound healing, helping patients choose safer care and avoid infections.

Nathan Ott, PharmD, discusses the evolution of pharmacists’ role in vaccine administration and how that role has changed since the COVID-19 pandemic and prior.

In a recent webinar sponsored by Drug Topics, pharmacy and insurance industry experts discuss the true impact of recent PBM reform efforts on the greater drug supply chain.

Community pharmacists can spot chronic wound red flags, boost diabetes control, and guide prevention for faster healing and safer care.

Pharmacists cut through wound-care aisle confusion, explaining simple steps, moist healing, and when basic dressings beat pricey ointments.

Sally Rafie, PharmD, BCPS, discusses current developments regarding access to the abortion pill and other notable events regarding women’s reproductive rights.

The most common mistake pharmacists can make when promoting their new clinical service is not marketing it.

Community pharmacists deliver fast wound assessment, OTC guidance, and prevention tips, supporting safe healing when clinics are closed and care feels urgent.

Matt Sample and Neal Cooper join to discuss the beginning stages of the FDA’s 7-year rollout of new NDCs for prescription drugs.

Community pharmacists guide minor wound care—clean, protect, and monitor—spot infection risks, and refer serious injuries quickly to prevent complications.

An Iowa independent pharmacy runs a cash-pay test‑to‑treat mini clinic, which streamlines workflow and expands patient access fast.

Rick Gates, chief pharmacy officer at Walgreens, helps introduce his organization’s innovative new ‘hybrid pharmacist’ role.

Pharmacists spot diabetes risk early, explain heart- and kidney-protecting meds, decode CGM data, and find affordable support.

Suzanne K. Higginbotham, PharmD, BCACP, CTTS, CDCES, further discusses her APhA 2026 presentation titled “Real-Time. Real Change. Rethinking CGM for Today's Patient.”

Sylvie Stacy, MD, MPH, introduces her work on GLP-1s for addiction and the new pathways this drug class can introduce for patients living with SUD.

Darren Mensch, PharmD, BCPS, BCACP, joins to discuss his presentation at APhA 2026 titled “Quality Wars: The AI Awakens in Pharmacy Practice.”

Sally Rafie, PharmD, BCPS, dives deeper into her APhA 2026 presentation titled “Lights, Camera, Access: Contraception Care at the Pharmacy.”

Pharmacists can build trust in buprenorphine care, handle early refill red flags, and point patients to resources to help them with substance use disorder.

Gretchen Garofoli, PharmD, BCACP, CTTS, FAPhA, provides her perspectives on the federal vaccine overhaul and its recent reversal in a Massachusetts federal court.

Harm reduction for pharmacists can include person-first language and stigma-free naloxone counseling that keeps patients with substance use disorder safer.

Many patients struggle with the everyday realities of staying on the medication, which can include uncomfortable adverse effects.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, provides nuance and understanding to the FDA’s recent push to move, essentially, ‘every’ drug to OTC formulation.

The SUPPORT Act 2025 lets pharmacists prescribe buprenorphine for opioid use disorder, but DEA training and state rules shape access and new formulations.

Mississippi pharmacies strengthen prenatal care with monthly check-ins, vitamins, aspirin, screenings, and community support for high-risk moms.

Across the United States, trafficking also takes the form of labor exploitation in farms, factories, and remote industrial regions.

Pharmacists spot subtle abuse and sexual health red flags, avoid profiling, and respond safely with resources while protecting HIPAA privacy.